{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:38:50Z","timestamp":1792719530644,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejogrb.2026.115506","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:11:24Z","timestamp":1792451484000},"page":"115506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor\/tezacaftor\/ivacaftor (ETI) therapy: a single-center descriptive cohort"],"prefix":"10.1016","volume":"327","author":[{"given":"Sophie","family":"Le Bars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Danner-Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9897-8493","authenticated-orcid":false,"given":"Norbert","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-0288","authenticated-orcid":false,"given":"Vincent","family":"Dochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115506_b0005","unstructured":"Vaincre la Mucoviscidose [Internet]. 2014 [cited 2024 Aug 31]. La mucoviscidose. Available from: https:\/\/www.vaincrelamuco.org\/vivre-avec\/la-mucoviscidose."},{"key":"10.1016\/j.ejogrb.2026.115506_b0010","unstructured":"Comprendre la mucoviscidose [Internet]. [cited 2024 Aug 31]. Available from: https:\/\/www.ameli.fr\/assure\/sante\/themes\/mucoviscidose\/comprendre-mucoviscidose."},{"key":"10.1016\/j.ejogrb.2026.115506_b0015","unstructured":"Inserm [Internet]. [cited 2024 Aug 31]. Mucoviscidose \u00b7 Inserm, La science pour la sant\u00e9. Available from: https:\/\/www.inserm.fr\/dossier\/mucoviscidose\/."},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115506_b0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115506_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2017.07.017","article-title":"Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis","volume":"17","author":"Kazmerski","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ejogrb.2026.115506_b0030","unstructured":"Vaincre la Mucoviscidose [Internet]. 2015 [cited 2024 Aug 31]. Registre fran\u00e7ais de la mucoviscidose. Available from: https:\/\/www.vaincrelamuco.org\/registredelamuco."},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115506_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1513\/AnnalsATS.201211-108OC","article-title":"Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis","volume":"10","author":"Schechter","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115506_b0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2020.09.002","article-title":"Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression","volume":"20","author":"Cohen-Cymberknoh","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115506_b0045","doi-asserted-by":"crossref","first-page":"98.e1","DOI":"10.1016\/j.ajog.2014.07.018","article-title":"Medical and obstetric complications among pregnant women with cystic fibrosis","volume":"212","author":"Patel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115506_b0050","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.124.4.1460","article-title":"The effect of pregnancy on survival in women with cystic fibrosis","volume":"124","author":"Goss","year":"2003","journal-title":"Chest"},{"issue":"300","key":"10.1016\/j.ejogrb.2026.115506_b0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejogrb.2024.06.045","article-title":"Obstetric and neonatal outcomes among pregnant patients with cystic fibrosis","volume":"1","author":"Amar","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115506_b0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.129.3.706","article-title":"Impact of pregnancy on women with cystic fibrosis","volume":"129","author":"McMullen","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115506_b0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/1471-0528.12040","article-title":"The outcome of pregnancies in women with cystic fibrosis\u2013single centre experience 1998\u20132011","volume":"120","author":"Thorpe-Beeston","year":"2013","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115506_b0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/14767058.2016.1161747","article-title":"Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis","volume":"30","author":"Jelin","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115506_b0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-0528.2000.tb11697.x","article-title":"The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977-1996","volume":"107","author":"Edenborough","year":"2000","journal-title":"BJOG"},{"issue":"10","key":"10.1016\/j.ejogrb.2026.115506_b0080","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/aogs.13185","article-title":"Pregnancy outcome in women with cystic fibrosis-related diabetes","volume":"96","author":"Reynaud","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2026.115506_b0085","unstructured":"Transplantation pulmonaire de l\u2019adulte en France, \u00e9tat des lieux \u2013 Acad\u00e9mie nationale de m\u00e9decine | Une institution dans son temps [Internet]. [cited 2024 Aug 31]. Available from: https:\/\/www.academie-medecine.fr\/transplantation-pulmonaire-de-ladulte-en-france-etat-des-lieux\/."},{"issue":"19","key":"10.1016\/j.ejogrb.2026.115506_b0090","article-title":"Cystic fibrosis: new challenges and perspectives beyond elexacaftor\/tezacaftor\/ivacaftor","volume":"31","author":"Terlizzi","year":"2025","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115506_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00404-023-06962-5","article-title":"Use of elexacaftor\/tezacaftor\/ivacaftor combination in pregnancy","volume":"309","author":"Cimino","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2026.115506_b0100","first-page":"236","article-title":"Therapeutic drug monitoring of elexacaftor, tezacaftor, and ivacaftor before, during, and after pregnancy in women with cystic fibrosis: an observational study","volume":"1","author":"Shad","year":"2025","journal-title":"Respir Med"},{"key":"10.1016\/j.ejogrb.2026.115506_b0105","unstructured":"Registre fran\u00e7ais de la mucoviscidose \u2014 Bilan des donn\u00e9es 2024. Vaincre la Mucoviscidose, Paris, November 2025. Available from: https:\/\/www.vaincrelamuco.org\/registredelamuco."},{"key":"10.1016\/j.ejogrb.2026.115506_b0110","unstructured":"Rapport ENP 2021\u202f: disponible en ligne \u2013 Enqu\u00eate Nationale P\u00e9rinatale [Internet]. [cited 2023 Jan 23]. Available from: https:\/\/enp.inserm.fr\/rapport-enp-2021-disponible-en-ligne\/."},{"key":"10.1016\/j.ejogrb.2026.115506_b0115","unstructured":"Valcheva I, Paterson I. Pregnancy outcomes in patients from a Scottish Adult Cystic Fibrosis Unit taking elexacaftor\/tezacaftor\/ivacaftor, 2020-present. Obstet Med. 2025 Feb 26;1753495X251319588. doi:10.1177\/1753495X251319588 PubMed PMID: 40027072; PubMed Central PMCID: PMC11866333."},{"key":"10.1016\/j.ejogrb.2026.115506_b0120","article-title":"Obstetric and neonatal outcomes in pregnancies from a dedicated cystic fibrosis-maternal health service: a retrospective study","author":"Scott","year":"2025","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115506_b0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.chest.2024.09.019","article-title":"Impact of cystic fibrosis transmembrane conductance regulator modulators on maternal outcomes during and after pregnancy","volume":"167","author":"Jain","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.ejogrb.2026.115506_b0130","unstructured":"SPF. Enqu\u00eate nationale p\u00e9rinatale. Rapport 2021. Les naissances, le suivi \u00e0 deux mois et les \u00e9tablissements [Internet]. [cited 2024 Sep 14]. Available from: https:\/\/www.santepubliquefrance.fr\/import\/enquete-nationale-perinatale.-rapport-2021.-les-naissances-le-suivi-a-deux-mois-et-les-etablissements."},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115506_b0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ejogrb.2026.115506_b0140","doi-asserted-by":"crossref","unstructured":"Jones GH, Walshaw MJ. Potential impact on fertility of new systemic therapies for cystic fibrosis. Paediatric Respiratory Reviews. 2015 Oct 1;Royal Society of Medicine \u2013 The 28th symposium: Cystic fibrosis in children and adults, 18th November 201416:25\u20137. doi:10.1016\/j.prrv.2015.07.013.","DOI":"10.1016\/j.prrv.2015.07.013"},{"issue":"15","key":"10.1016\/j.ejogrb.2026.115506_b0145","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.16417","article-title":"Extent of foetal exposure to maternal elexacaftor\/tezacaftor\/ivacaftor during pregnancy","volume":"181","author":"Li","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115506_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116155","article-title":"Fetal drug exposure after maternally administered CFTR modulators Elexacaftor\/Tezacaftor\/Ivacaftor in a rat model","volume":"171","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115506_b0155","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcf.2022.10.004","article-title":"Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:18:51Z","timestamp":1792718331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526005749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S0301211526005749"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115506","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor\/tezacaftor\/ivacaftor (ETI) therapy: a single-center descriptive cohort","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115506"}}